Development and validation of a melanoma risk score based on pooled data from 16 case-control studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 5, 2015, Pages 817-824

  Davies, John R ^a,w   Chang, Yu Mei ^a   Bishop, D Timothy ^a   Armstrong, Bruce K ^b   Bataille, Veronique ^c,d   Bergman, Wilma ^e   Berwick, Marianne ^f   Bracci, Paige M ^g   Elwood, J Mark ^h   Ernstoff, Marc S ⁱ   Green, Adele ^j   Gruis, Nelleke A ^e   Holly, Elizabeth A ^g   Ingvar, Christian ^k   Kanetsky, Peter A ^l   Karagas, Margaret R ^m   Lee, Tim K ⁿ   Le Marchand, Loïc ^o   Mackie, Rona M ^p   Olsson, Håkan ^k   Østerlind, Anne ^q   Rebbeck, Timothy R ^r   Reich, Kristian ^s   Sasieni, Peter ^t   Siskind, Victor ^j   Swerdlow, Anthony J ^u   Titus, Linda ^m   Zens, Michael S ^m   Ziegler, Andreas ^v   Gallagher, Richard P ⁿ   Barrett, Jennifer H ^a   Newton Bishop, Julia ^a   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Hemel Hempstead General Hospital   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF AUCKLAND   (New Zealand)

ⁱ DARTMOUTH MEDICAL SCHOOL   (United States)

^j ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^m NORRIS COTTON CANCER CENTER   (United States)

ⁿ BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^o UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^p UNIVERSITY OF GLASGOW   (United Kingdom)

^q University of Pennsylvania ^*  (Denmark)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s DERMATOLOGIKUM HAMBURG   (Germany)

^t QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^u INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^v UNIVERSITY OF LÜBECK   (Germany)

^w ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; ATTRIBUTABLE RISK; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; CUTANEOUS MELANOMA; FAMILY HISTORY; FEMALE; HAIR COLOR; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; PRIORITY JOURNAL; SUN EXPOSURE; SUNBURN; VALIDATION STUDY; MELANOMA; METHODOLOGY; RISK FACTOR; SKIN NEOPLASMS;

ALGORITHMS; CASE-CONTROL STUDIES; HUMANS; MELANOMA; RESEARCH DESIGN; RISK FACTORS; SKIN NEOPLASMS;

EID: 84938582672     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-1062     Document Type: Article

References (48)

1. Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignantmelanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 2013;2:447-56.
2. Hill D, White V, Marks R, Borland R. Changes in sun-related attitudes and behaviours, and reduced sunburn prevalence in a population at high risk of melanoma. Eur J Cancer Prev 1993;2:447-56.
3. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005;41:2040-59.
4. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009;38:814-30.
5. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Metaanalysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005;41:28-44.
6. Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer 2009; 124:420-8.
7. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011;43:1108-13.
8. Newton-Bishop JA, Chang YM, Elliott F, Chan M, Leake S, Karpavicius B, et al. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 2011;47:732-41.
9. Newton-Bishop JA, Chang YM, Iles MM, Taylor JC, Bakker B, Chan M, et al. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010;19:2043-54.
10. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45-60.
11. Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure-the Western Canada Melanoma Study. Int J Cancer 1985;35:427-33.
12. Buuren van S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. Journal of Statistical Software 2011;45:1-67.
13. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
14. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
16. Cancer Research UK. Skin cancer incidence statistics. 2014 22/04/2014 [cited 2014 8/12/2014]; Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/skin/incidence/uk-skin-cancer-incidence-statistics
17. Office for National Statistics. Death Registrations Summary Tables, England and Wales, 2013. 2013 16/07/2014 [cited 2014 8/12/2014]; Available from: http://www.ons.gov.uk/ons/rel/vsob1/death-reg-sum-tables/2013/index.html
18. Office for National Statistics. Howhave mortality rates by age changed over the last 50 years? 2014 13/10/2014 [cited 2014 8/12/2014]; Available from: http://www.ons.gov.uk/ons/rel/vsob1/death-reg-sum-tables/2013/sty-mortality-rates-by-age.html
19. Mermelstein RJ, Riesenberg LA. Changing knowledge and attitudes about skin cancer risk factors in adolescents. Health Psychol 1992;11:371-6.
20. NIH. Melanoma Risk Assessment Tool. 2008 09/10/2008 [cited 2015 21/1/2015]; Available from: http://www.cancer.gov/melanomarisktool/
21. Fears TR, Guerry Dt, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006;24:3590-6.
22. Sneyd MJ, Cameron C, Cox B. Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid. BMC Cancer 2014; 14:359.
23. Government NSW. Dark side of tanning. 2010 [cited 2015 21/1/2015]; Available from: http://www.darksideoftanning.com.au/reduce-risk/quiz. aspx
24. Health HSoP. Disease Risk Index. 2008 [cited 2015 21/1/2015]; Available from: http://www.diseaseriskindex.harvard.edu/update/hccpquiz.pl?lang=english&func=home&quiz=melanoma
25. Eiser JR. Communication and interpretation of risk. Br Med Bull 1998;54:779-90.
26. Vahabi M. Verbal versus numerical probabilities: does format presentation of probabilistic information regarding breast cancer screening affect women's comprehension? Health Educ J 2010;69:150-63.
27. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-90.
28. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol 2007;57:60-6.
29. Whiteman DC, Green AC. A risk prediction tool for melanoma? Cancer Epidemiol Biomarkers Prev 2005;14:761-3.
30. Berry DC, Knapp PR, Raynor T. Is 15 per cent very common? Informing people about the risks of medication side effects. Int J Pharm Pract 2002;10:145-51.
31. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
32. Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011;60:1475-81.
33. Vuong K, McGeechan K, Armstrong BK, Cust AE. Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatol 2014;150:434-44.
34. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996;73:1605-11.
35. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
36. Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990;19:801-10.
37. Green A, Siskind V, Bain C, Alexander J. Sunburn and malignant melanoma. Br J Cancer 1985;51:393-7.
38. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.
39. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403-14.
40. Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, et al. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 2001;10: 509-13.
41. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003;120:1087-93.
42. Le Marchand L, Saltzman BS, Hankin JH, Wilkens LR, Franke AA, Morris SJ, et al. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol 2006;164:232-45.
43. Mossner R, Anders N, Konig IR, Kruger U, Schmidt D, Berking C, et al. Variations of themelanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 2007;298:371-9.
44. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant-melanoma. II. Importance of UV-light exposure. Int J Cancer 1988;42:319-24.
45. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. BrMed J (Clin Res Ed) 1986;292:1555-9.
46. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson JJ, Cole BF, Ernstoff MS. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer 2005;116:144-9.
47. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N, Brandt L, et al. Use of sunbeds or sunlamps and malignant-melanoma in southern Sweden. Am J Epidemiol 1994;140:691-9.
48. Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 2000;82:1593-9.